SCHEMBL5229634

SCHEMBL5229634

Cc1ccc(C(C#N)=NOS(C)(=O)=O)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
MAPT P10636 4/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
LMNA P02545 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
TDP1 Q9NUW8 4/20 0.35
PTGS2 P35354 1/20 0.34
HPGD P15428 2/20 0.34
PKM P14618 1/20 0.34
GAA P10253 1/20 0.34
CYP1A2 P05177 2/20 0.33
MAPK1 P28482 2/20 0.33
NFKB1 P19838 1/20 0.33
S100A4 P26447 1/20 0.33
MTOR P42345 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6706095 1.00 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A
SCHEMBL19418706 0.93 PLA2G7 (0.36) MAPTNPC1PLA2G7HSD17B10
SCHEMBL9891196 0.93 PLA2G7 (0.36) MAPTNPC1PLA2G7HSD17B10
SCHEMBL18431381 0.93 PLA2G7 (0.36) MAPTNPC1PLA2G7HSD17B10
SCHEMBL14375142 0.87 HSD17B10 (0.38) ALDH1A1SMN1; SMN2MAPTLMNAPLA2G7
SCHEMBL10233179 0.87 ENPP2 (0.37) ALDH1A1SMN1; SMN2MAPTLMNAMEN1
SCHEMBL18957974 0.86 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A
SCHEMBL10097224 0.86 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A
SCHEMBL10083959 0.86 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A
SCHEMBL296477 0.85 GSK3B (0.36) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040013974-A1 Alkylsulfonyloximes for high-resolution i-line photoresists of high sensitivity DIETLIKER KURT (CH) 2004-01-22 US claimed
EP-0925529-A1 ALKYSULFONYLOXIMES FOR HIGH-RESOLUTION I-LINE PHOTORESISTS OF HIGH SENSITIVITY Ciba SC Holding AG (CH) 1999-06-30 EP claimed
WO-1998010335-A1 ALKYSULFONYLOXIMES FOR HIGH-RESOLUTION I-LINE PHOTORESISTS OF HIGH SENSITIVITY CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 1998-03-12 WO claimed
CN-120044752-A Photosensitive resin composition 东京应化工业株式会社 2025-05-27 CN disclosed
CN-116583784-A Resist composition and resist pattern forming method 东京应化工业株式会社 2023-08-11 CN disclosed
WO-2022138648-A1 RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN 東京応化工業株式会社 2022-06-30 WO disclosed
CN-112987497-A Resist composition and resist pattern forming method 东京应化工业株式会社 2021-06-18 CN disclosed
EP-2131423-B1 NEGATIVE ELECTRODE BASE MEMBER TOKYO OHKA KOGYO CO LTD (JP) 2017-11-15 EP disclosed
US-20160195814-A1 PATTERN FORMATION METHOD, ELECTRONIC-DEVICE PRODUCTION METHOD, AND PROCESSING AGENT FUJIFILM CORPORATION (JP) 2016-07-07 US disclosed
EP-1806619-B1 RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, AND COMPOUND TOKYO OHKA KOGYO CO LTD (JP) 2015-04-22 EP disclosed
US-8795944-B2 Actinic ray-sensitive or radiation-sensitive resin composition and pattern forming method using the composition FUJIFILM CORPORATION (JP) 2014-08-05 US disclosed
EP-0848289-B1 Negative-working chemical sensitization photoresist composition TOKYO OHKA KOGYO CO LTD (JP) 2002-02-27 EP disclosed
EP-0821274-B1 Chemical-sensitization resist composition TOKYO OHKA KOGYO CO LTD (JP) 2001-11-14 EP disclosed
US-6245930-B1 AN OXIMESULFONATE COMPOUND CAPABLE OF GIVING POSITIVELY OR NEGATIVELY PATTERNED RESIST LAYER OF EXCELLENT PATTERN RESOLUTION, CROSS SECTIOANL PROFILE, AND HIGH SENSITIVITY TOKYO OHKA KOGYO CO., LTD. (JP) 2001-06-12 US disclosed
US-5976760-A Chemical-sensitization resist composition TOKYO OHKA KOGYO CO., LTD. (JP) 1999-11-02 US disclosed
US-5928837-A Negative-working chemical-sensitization photoresist composition comprising oxime sulfonate compounds TOKYO OHKA KOGYO CO., LTD. (JP) 1999-07-27 US disclosed
EP-0925529-A1 ALKYSULFONYLOXIMES FOR HIGH-RESOLUTION I-LINE PHOTORESISTS OF HIGH SENSITIVITY Ciba SC Holding AG (CH) 1999-06-30 EP disclosed
EP-0848289-A1 Negative-working chemical sensitization photoresist composition TOKYO OHKA KOGYO CO., LTD. (JP) 1998-06-17 EP disclosed
WO-1998010335-A1 ALKYSULFONYLOXIMES FOR HIGH-RESOLUTION I-LINE PHOTORESISTS OF HIGH SENSITIVITY CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 1998-03-12 WO disclosed
EP-0821274-A1 Chemical-sensitization resist composition TOKYO OHKA KOGYO CO., LTD. (JP) 1998-01-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040013974-A1 Alkylsulfonyloximes for high-resolution i-line photoresists of high sensitivity SULT1E1, CCNT1, CCNE1 ALDH1A1 1150/4885SMN1; SMN2 1833/4885MAPT 4376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.